The clinical translation of cell therapies is limited by the high cost and labor-intensive manufacturing of therapeutic cells. While porous sponges enhance viral transduction, the underlying mechanism ...
Read DPM's full ASX announcement titled "Q2 2026 MD&A" from 31 Jul 2026, on Market Index.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results